uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 17, 2018

FDA Warns Seller Reishi Mushroom Supplements

On February 7, 2018, the FDA issued a warning letter to Reishi D. International, Inc., following a facility inspection which found the company's Reishi D. supplement to be adulterated because it was prepared, packed, or held under conditions that violate Current Good Manufacturing Practices for dietary supplements. 

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at